94 related articles for article (PubMed ID: 29582639)
1. Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas.
El-Saadany S; El-Demerdash T; Helmy A; Mayah WW; El-Sayed Hussein B; Hassanien M; Elmashad N; Fouad MA; Basha EA
Asian Pac J Cancer Prev; 2018 Mar; 19(3):811-817. PubMed ID: 29582639
[TBL] [Abstract][Full Text] [Related]
2. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H; Wang J; Zhang H; Wu Y; Wang K; Wang X; Xu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):131-139. PubMed ID: 38310085
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe.
Han HH; Qiu YJ; Shi YY; Wen W; He XP; Dong LW; Tan YX; Long YT; Tian H; Wang HY
Theranostics; 2018; 8(12):3268-3274. PubMed ID: 29930728
[TBL] [Abstract][Full Text] [Related]
5. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma.
Guo M; Zhang H; Zheng J; Liu Y
J Cancer; 2020; 11(8):2008-2021. PubMed ID: 32127929
[TBL] [Abstract][Full Text] [Related]
7. Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.
Xu D; Su C; Sun L; Gao Y; Li Y
Ann Hepatol; 2019; 18(1):58-67. PubMed ID: 31113610
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.
Majeed S; Mushtaq S; Azam M; Akhtar N; Hussain M; Loya A
J Pak Med Assoc; 2018 Jul; 68(7):1029-1031. PubMed ID: 30317296
[TBL] [Abstract][Full Text] [Related]
9. GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma.
Ramadan A; Ghanem HM; Mohamed AA; Elshobaky M; El Agawy W; Gawad EAHA; Eldeeb HH; Ezz Al Arab MR; Kamal MM
Rep Pract Oncol Radiother; 2023; 28(4):485-495. PubMed ID: 37795234
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of Daidzein against Diethylnitrosamine/Carbon Tetrachloride-Induced Hepatocellular Carcinoma in Male Rats.
Bashandy SAE; Ebaid H; Al-Tamimi J; Hassan I; Omara EA; Elbaset MA; Alhazza IM; Siddique JA
Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759583
[TBL] [Abstract][Full Text] [Related]
11. A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers.
Burciu C; Șirli R; Bende R; Popa A; Vuletici D; Miuțescu B; Rațiu I; Popescu A; Sporea I; Dănilă M
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046471
[TBL] [Abstract][Full Text] [Related]
12. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang D; Zhang Y; Wang Y; Xu F; Liang J; Wang W
Front Oncol; 2022; 12():1012418. PubMed ID: 36212469
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Wang C; Shao X; Zhang X; Xie C; Yu J; Xu X; Yang J; Li Y; Xu W
Transl Cancer Res; 2020 Jan; 9(1):128-136. PubMed ID: 35117166
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities.
Natu A; Singh A; Gupta S
World J Hepatol; 2021 Nov; 13(11):1568-1583. PubMed ID: 34904030
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy.
Huang SL; Wang YM; Wang QY; Feng GG; Wu FQ; Yang LM; Zhang XH; Xin HW
Front Genet; 2021; 12():691391. PubMed ID: 34306031
[TBL] [Abstract][Full Text] [Related]
17. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
18. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
Zhao X; Zou J; Wang Z; Li G; Lei Y
Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
